Found: 44
Select item for more details and to access through your institution.
Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 2, p. 133, doi. 10.1007/s40261-020-00974-8
- By:
- Publication type:
- Article
Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 5, p. 441, doi. 10.1007/s40261-019-00764-x
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 7, p. 631, doi. 10.1007/s40261-018-0650-4
- By:
- Publication type:
- Article
The Effect of Food on Doravirine Bioavailability: Results from Two Pharmacokinetic Studies in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 6, p. 571, doi. 10.1007/s40261-017-0512-5
- By:
- Publication type:
- Article
Estimating time to steady state using the effective rate of drug accumulation.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 1, p. 27, doi. 10.1002/pst.404
- By:
- Publication type:
- Article
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 2, p. 150, doi. 10.1016/S0009-9236(03)00123-1
- By:
- Publication type:
- Article
Effects of the neurokinin<sub>1</sub> receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 17, doi. 10.1016/S0009-9236(03)00066-3
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men.
- Published in:
- Clinical Pharmacology & Therapeutics, 1994, v. 56, n. 4, p. 377, doi. 10.1038/clpt.1994.152
- By:
- Publication type:
- Article
Investigation of the sedative and congnitive effects of cyclobenzaprine compared with diphenhydramine and placebo using a computerized test battery.
- Published in:
- Drug Development Research, 1992, v. 27, n. 1, p. 33, doi. 10.1002/ddr.430270104
- By:
- Publication type:
- Article
Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 665, doi. 10.1007/s00228-018-2585-3
- By:
- Publication type:
- Article
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 593, doi. 10.1007/s00228-017-2216-4
- By:
- Publication type:
- Article
Drug‐Drug Interaction of Letermovir and Atorvastatin in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 4, p. 420, doi. 10.1002/cpdd.1071
- By:
- Publication type:
- Article
Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 198, doi. 10.1002/cpdd.852
- By:
- Publication type:
- Article
Pharmacokinetic Interactions Between the Fixed‐Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 952, doi. 10.1002/cpdd.702
- By:
- Publication type:
- Article
Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 962, doi. 10.1002/cpdd.701
- By:
- Publication type:
- Article
Thorough QTc Evaluation and the Safety of Supratherapeutic Doses of Odanacatib in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 861, doi. 10.1002/cpdd.698
- By:
- Publication type:
- Article
A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension.
- Published in:
- Pediatric Nephrology, 2007, v. 22, n. 5, p. 695, doi. 10.1007/s00467-006-0399-5
- By:
- Publication type:
- Article
Relative bioavailability of diazoxide, manufactured at two different international locations, in healthy participants under fasting conditions: an open-label, two-stage, adaptive, sequential two-period crossover study.
- Published in:
- AAPS Open, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s41120-017-0013-x
- By:
- Publication type:
- Article
Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 10, p. 1331, doi. 10.1002/jcph.1423
- By:
- Publication type:
- Article
Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 5, p. 666, doi. 10.1002/jcph.1052
- By:
- Publication type:
- Article
Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effect of Aprepitant 40 mg on Cytochrome P-450 2C9 Activity: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study in Healthy Young Adults.
- Published in:
- Journal of Applied Research, 2009, v. 9, n. 4, p. 123
- By:
- Publication type:
- Article
Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1240, doi. 10.1111/j.1365-2125.2012.04471.x
- By:
- Publication type:
- Article
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 68, n. 4, p. 535, doi. 10.1111/j.1365-2125.2009.03465.x
- By:
- Publication type:
- Article
Evaluation of Methods for Estimating Time to Steady State with Examples from Phase 1 Studies.
- Published in:
- AAPS Journal, 2008, v. 10, n. 1, p. 141, doi. 10.1208/s12248-008-9014-y
- By:
- Publication type:
- Article
Pharmacokinetics of famotidine in infants.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The minimal impact of food on the pharmacokinetics of ridaforolimus.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 177, doi. 10.1007/s00280-012-1897-8
- By:
- Publication type:
- Article
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1247, doi. 10.1007/s00280-011-1819-1
- By:
- Publication type:
- Article
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1313, doi. 10.1007/s00280-010-1421-y
- By:
- Publication type:
- Article
Lack of Meaningful Effect of Ridaforolimus on the Pharmacokinetics of Midazolam in Cancer Patients: Model Prediction and Clinical Confirmation.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 11, p. 1256, doi. 10.1002/jcph.331
- By:
- Publication type:
- Article
Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 12, p. 1712, doi. 10.1177/0091270010387792
- By:
- Publication type:
- Article
Single- and Multiple-Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, in Adults.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 12, p. 1367, doi. 10.1177/0091270010361741
- By:
- Publication type:
- Article
Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 7, p. 792, doi. 10.1177/0091270006288954
- By:
- Publication type:
- Article
Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 3, p. 291, doi. 10.1177/0091270005283467
- By:
- Publication type:
- Article
The Pharmacokinetics of Enalapril in Children and Infants with Hypertension.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 10, p. 1064, doi. 10.1177/009127000104101004
- By:
- Publication type:
- Article
Antiplatelet Effects of MK-852, a Platelet Fibrinogen Receptor Antagonist, in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 5, p. 496, doi. 10.1177/009127000004000511
- By:
- Publication type:
- Article
Rizatriptan, a Novel 5-HTlB/lD Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 1, p. 74, doi. 10.1177/009127000004000110
- By:
- Publication type:
- Article
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 5, p. 1935, doi. 10.1111/cts.13048
- By:
- Publication type:
- Article
Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 599, doi. 10.1111/cts.12917
- By:
- Publication type:
- Article
Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 3, p. 462, doi. 10.1111/cts.12728
- By:
- Publication type:
- Article
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 553, doi. 10.1111/cts.12564
- By:
- Publication type:
- Article
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 562, doi. 10.1111/cts.12565
- By:
- Publication type:
- Article